← Eichor
Study identifier: NCT06123650 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Post Stroke Dysphagia: Effect of Adding rTMS to Conventional Therapy on the Prevalence of Pneumonia.

Condition: Stroke, Acute · Dysphagia · Pneumonia  ·  Sponsor: Cairo University

PhaseNA
Planned participants70
Who can joinAll sexes, 49 Years to 65 Years
Healthy volunteersNo

About this study

BACKGROUND: Dysphagia is one of the most life-threatening stroke complications. Dysphagic stroke patients are at increased risk of aspiration pneumonia. Pneumonia accounts for at least 10% of post stroke deaths within 30 days of hospitalization after stroke. rTMS is effective in improving post-stroke dysphagia and swallowing coordination after stimulation of the unaffected hemisphere, however it's efficacy on the prevalence of pneumonia has not yet been examined. Purpose of the study: To determine the effect of adding low frequency repetitive transcranial magnetic stimulation to conventional oropharyngeal physical therapy program on the prevalence of aspiration pneumonia in in patients with post stroke dysphagia.

This description comes directly from the study's public registry record.

Talk to the study team

Engy B. Moustafa, PhD  ·  00201099445112  ·  engybm.saleh@cu.edu.eg

Moshera H. Darwish, PhD  ·  00201015163617  ·  dr.moshera11@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Faculty of Physical Therapy, Cairo UniversityGiza, Giza Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06123650